These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analyses of the Turkish National Intravenous Thrombolysis Registry. Kutluk K, Kaya D, Afsar N, Arsava EM, Ozturk V, Uzuner N, Giray S, Topcuoglu MA, Gungor L, Sirin H, Yaka E, Ozdemir O, Dalkara T, Turkish Thrombolysis Study Group. J Stroke Cerebrovasc Dis; 2016 May; 25(5):1041-1047. PubMed ID: 26853139 [Abstract] [Full Text] [Related]
4. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia. Al Khathaami AM, Al Bdah B, Tarawneh M, Alskaini M, Alotaibi F, Alshalan A, Almuhraj M, Aldaham D, Alotaibi N. J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225 [Abstract] [Full Text] [Related]
10. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. Lancet; 2012 Jun 23; 379(9834):2352-63. PubMed ID: 22632908 [Abstract] [Full Text] [Related]
11. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC. Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):543-9. PubMed ID: 24046398 [Abstract] [Full Text] [Related]
12. Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion. Kahles T, Mono ML, Heldner MR, Baumgartner RW, Sarikaya H, Luft A, Bohlhalter S, Traenka C, Engelter ST, Kurka N, Köhrmann M, Curtze S, Michel P, Tatlisumak T, Nedeltchev K. Stroke; 2016 Aug 01; 47(8):2133-5. PubMed ID: 27364530 [Abstract] [Full Text] [Related]
17. Intravenous Tissue Plasminogen Activator in Stroke Mimics. Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y. Circ Cardiovasc Qual Outcomes; 2019 Aug 01; 12(8):e005609. PubMed ID: 31412730 [Abstract] [Full Text] [Related]
18. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study. Xu X, Wang D, Wang F, Norton C, Liu X, Selim M. J Stroke Cerebrovasc Dis; 2018 Sep 01; 27(9):2381-2387. PubMed ID: 29778315 [Abstract] [Full Text] [Related]